CTOs on the Move

Amplyx Pharmaceuticals

www.amplyx.com

 
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The resulting, new therapeutic creates a more targeted molecule with the goal of improving treatment outcomes and improving compliance with treatment regimens. Our initial development areas are in oncology and infectious disease.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.amplyx.com
  • 3210 Merryfield Row
    San Diego, CA USA 92121-1126
  • Phone: 415.578.3263

Executives

Name Title Contact Details

Funding

Amplyx Pharmaceuticals raised $40.5M on 11/11/2015
Amplyx Pharmaceuticals raised $53M on 05/19/2020

Similar Companies

Cassini Technologies

Driven by curiosity and love of science Cassini has been dedicated to push the boundaries of corneal diagnostics solutions ✓ Advised by top surgeons

Tilray

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in twelve countries spanning five continents.

KESIN PHARMA

Kesin Pharma is a specialty pharmaceutical company that offers a variety of products, including unit dose drug repackaging for liquid medications and creams/ointments.

Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company`s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Neotropix

Neotropix is a Malvern, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.